The relationship between GLP-1R agonists and tumor growth is not well defined; studies have shown that for some tumors, such as liver cancer, GLP-1R agonists inhibit their growth, but for others, such as thyroid cancer, GLP-1R agonists actually accelerate their growth. Here, GLP1R is linked to thyroid gland carcinoma.